In this study, we sought to determine whether liposomal preparations containing a phospholipid conjugate of methotrexate and dimyristoylphosphatidylethanolamine (MTX-y-DMPE) incorporated within their lipid membranes are effective in suppressing established joint inflammation in a monoarticular model of arthritis in the rat. Arthritis was induced in the right knee joint of Lewis rats. The rats were treated with a single intra-articular injection of either free methotrexate (MTX), liposomal MTX [MTX-multilamellar vesicles (MLV>1.2 /im or MTX-small unilamellar vesicles (SUV>100 nm], control liposomes (E-LIPO) or saline into the inflamed knee 7 days after arthritis induction. There was no significant difference in knee swelling in MTX-, salineand E-LIPO-treated rats up to 21 days after treatment. However, MTX-MLV treatment produced a significant reduction in knee swelling (26.5 ± 6.0%; mean ± S.E.M.) 1 day after intra-articular injection compared with MTX (3.5 ± 3.5%) and MTX-SUV (14.4 ± 2.4%), respectively. Over the next 20 days, knee swelling in MTX-MLV-treated rats fell progressively and almost returned to normal. MTX-MLV treatment also inhibited the cellular infiltration associated with the arthritis. Large multilamellar liposomal preparations of MTX-y-DMPE are more effective than free MTX and MTX-SUV in suppressing inflammation. Their differential effects in treating the antigen-induced arthritis model are related to their retention within the joint space.
ATTEMPTS to improve the efficacy and reduce the toxicity of methotrexate (MTX), by administering the drug intra-articularly, have not been successful in patients with rheumatoid arthritis (RA) since adequate concentrations of the drug could not be maintained within the joint [1] [2] [3] . Alternative formulations, achieved by encapsulating MTX within the aqueous compartments of multilamellar liposomes, can increase, 80-fold, the retention of the drug in the inflamed knee joints of rabbits with antigen-induced arthritis [4] . However, neither free nor liposomal MTX affected the degree of synovitis after intra-articular injection of rabbits with established antigen-induced arthritis [5] . The lack of anti-inflammatory effect was attributed to poor formulation characteristics and rapid leakage of MTX from the liposomes; MTX being detected in plasma within a few minutes after injection.
Drug leakage is not a problem if MTX is incorporated, as a minor integral component, within the liposomal bilayer. With a view to increasing the lipophilicity of MTX, allowing it to be incorporated into the phospholipid bilayers of liposomes, we have previously reported the synthesis of the methotrexate analogue (MTX-y-DMPE) in which the phospholipid dimyristoylphosphatidylethanolamine (DMPE) is covalently bound to the y-carboxylic acid residue in the glutamyl portion of MTX by an amide linkage [6] . We have shown, in vitro, that a liposomal preparation containing this conjugate inhibited the release of three important pro-inflammatory mediators, namely tumour necrosis factor (TNF) and prostaglandin (PGE 2 ) from lipopolysaccharide (LPS)-stimulated rat peritoneal macrophage [7] , and TNF and interleukin-1 (IL-1) from LPS-stimulated human peripheral blood monocytes [8] .
This study seeks to determine whether an intraarticular injection of liposomally conjugated MTX-y-DMPE is more effective than free MTX in suppressing established joint inflammation in rats with a monoarticular antigen-induced arthritis.
MATERIALS AND METHODS

Liposome preparation
Liposomes were produced by following the method originally described by Bangham et al. [9] . Briefly, a dry phospholipid film containing egg lecithin, cholesterol and phosphatidic acid to a molar ratio of 7:2:1 (200 //mol of lipid in total; Lipid Products, S. Nutfield, Surrey) and 4.0 mg of MTX-y-DMPE was prepared by rotary evaporation. Multilamellar vesicles (MTX-MLV; 1.2 fim) were produced upon addition of 2 ml of 0.9% (w/v) saline. MTX-MLV was then divided into two 1.0 ml aliquots. Small unilamellar vesicles (MTX-SUV) were produced from one aliquot of MTX-MLV by probe sonication (MSC Soniprep 150, 10 mm probe), a mean size of 100 nm was achieved after two 6 nm amplitude bursts for 5 min followed by one 10 fim burst for 5 min; the sample being immersed in an ice-bath throughout all the sonication steps. Titanium fragments (from the probe) were separated from the liposomal preparation by centrifugation at 13 000r.p.m. for 10 min. Large multilamellar lipo-somes containing 100 ^mol of 7:2:1 lipid mix in 1.0 ml 0.9% saline (E-LIPO) were also prepared. Liposomes were sized by photon correlation spectroscopy (Autosizer Lo-C and series 7032 multi-8 Correlator; Malvern Instruments Limited, Springlane South).
Animals
Male inbred Lewis rats (180-200 g) were obtained from Bantin and Kingman (The Field Station, Grimston, Hull). The animals were housed in cages of five, allowed food and water ad libitum, and kept in the Biomedical Services Department for 1 week prior to their first immunization. The animals were housed in light/dark cycles of 12 h.
Arthritis induction
Arthritis was induced in the right knee joint of each rat by following a method previously described by Griffiths [10] . Briefly, on two occasions 1 week apart, male Lewis rats (200 g) were injected s.c. with an emulsion of equal volumes of methylated bovine serum albumin (mBSA; 0.5 mg; Sigma Chemical Co.) and Freund's complete adjuvant (0.25 mg Mycobacterium tuberculosis; Sigma Chemical Co.). Fourteen days after the second immunization, the rats were given two intra-articular injections: mBSA (0.5 mg in 50 ii\ saline) into the right knee and 50 /zl saline into the left knee joint under halothane/oxygen anaesthesia. One day after this inducing dose, the rats developed inflammation in the right knee which peaked after 3 days. The development of arthritis was monitored at regular intervals by measuring knee diameters (mean of three readings), with the joint flexed at an angle of 90°, using a digital micrometer.
Treatment of antigen-induced arthritis
Seven days after the intra-articular dose of mBSA, the rats were divided into five matched groups (six rats per group). At this time (day 0), the rats were injected with 100 ^1 of test agent into the right knee (inflamed) and 100 /zl saline (0.9% w/v) into the left knee 
Histological grading of knee joint sections
Rats from different treatment groups were killed 28 days after arthritis induction (21 days after intra-articular injection of the test substance). The knee joints were removed in toto and fixed in formalin-buffered saline 1 week before histological processing. The joints were decalcified and embedded in paraffin wax, then sectioned in the sagittal plane at 5 /jm and stained with haematoxylin/eosin. All sections were coded prior to assessment to eliminate observer bias and subsequently scored by an independent observer. The sections were graded subjectively on a scale of 0-4: 0 = normal; 1 = minimal synovial infiltration; 2 = moderate synovial infiltrate maybe inflammatory exudate in joint space; 3 = severe synovial infiltration and inflammatory exudate; 4 = severe synovial infiltration, inflammatory exudate and full-thickness cartilage destruction with bone erosion.
Liposome retention studies
Antigen arthritis was induced in the right knee joint of 12 male Lewis rats. The rats were divided into three equal groups (n = 4) and the animals received either 
Preparation of blood samples for beta counting
One hundred microlitres of hyamine hydroxide (1 M solution in methanol; ICN Radiochemicals) were added to each blood sample; after thorough mixing, the samples were incubated at 37°C for 30 min. After bleaching overnight with 150/il hydrogen peroxide (100 vol Fisons Scientific Equipment), 4.0 ml scintillation fluid were added to each sample (CytoScint; ICN Radiochemicals) and ^-radioactivity quantified (Wallac 1411 liquid scintillation counter).
Preparation of knee joints for beta counting
Weighed knee joints were liquidized in 5.0 ml deionized water using a sonic probe (Silverson sealed unit). Hyamine hydroxide (13 ml) was then added to solubilize the tissue and this mixture was incubated overnight at 37°C before the addition of 1.0 ml of hydrogen peroxide. After 24 h at 30 c C, a 2.0 ml aliquot from each sample was taken and 15 ml scintillant were added prior to counting.
Statistics
The one-way analysis of variance (ANOVA) was used to determine whether knee swelling was significantly different between MTX-, MTX-SUV-, MTX-MLV-, E-LIPO-and saline-treated rats from day 0 (baseline) to day 21. The modified Student's /-test (Bonferroni method for multiple comparisons) was used to identify which groups were different. RESULTS On day 0 (treatment day), baseline (100%) knee swelling (mean ± S.E.M.) in MTX-, MTX-SUV-, MTX-MLV-, E-LIPO-and saline-treated rats was 3.5 ±0.15, 3.23 ± 0.2, 3.92 ± 0.25, 3.22 ± 0.4 and 4.1 ± 0.15 mm, respectively. There was no significant difference (ANOVA) in knee swelling between the groups.
Free MTX-, E-LIPO-and saline-treated rats were included in the study as controls. When these three control groups were compared, there was no significant difference (ANOVA) in knee swelling from day 0 to day 21 (Fig. la) . Therefore, knee swelling data for MTX-MLV-and MTX-SUV-treated rats were compared with MTX-treated rats to determine whether By applying Wilcoxon's sum of ranks test (1945), the overall histological inflammatory scores in MTX-MLV-treated rats were significantly lower than those in saline-treated controls (P < 0.05). Sections from rats treated with free MTX were not significantly different from those from saline-treated controls.
'Indicates the presence of bone erosions.
intra-articular injection of liposomally conjugated MTX-y-DMPE could modify the course of the monoarticular arthritis. The effect of MTX, MTX-SUV and MTX-MLV treatment on right knee swelling is represented in Fig. lb . Between day 1 and day 21, MTX-SUV had a more beneficial effect than the free drug on knee swelling; however, this effect was not statistically significant. In contrast, 1 day after treatment, knee swelling (mean ± S.E.M.) in MTX-MLV-treated rats (73.5 ± 6.0%; P < 0.04) was significantly less than in MTX (96.5 ± 3.5%) treated rats. This difference remained significant at all time points to day 21 where knee swelling had decreased to 12.1 ±2.1% for MTX-MLV (P < 0.002) treated rats and 90 ± 7.5% for MTX-treated rats. Joint swelling in MTX-MLVtreated rats was also significantly less than in MTX-SUV-treated rats on day 14 (53 ± 6.4%; P < 0.01) and day 21 (60 ± 6.9%; P < 0.002).
The results of the histological examination of decalcified joint sections are summarized in Table I and Fig. 2a and b . At the end of the study, 21 days post-treatment, there was no significant difference in overall inflammatory score between saline-and MTX-treated rats (as assessed by Wilcoxon's sum of ranks test, 1945). The overall inflammatory scores in MTX-MLV-treated rats were significantly lower (P < 0.05) than those in saline-treated controls. In addition, only one of six sections from animals treated with MTX-MLV showed cartilage and bone erosions compared with four of six sections from saline-treated controls.
The rate at which pH]MTX and the liposomal preparations MTX-[ (Fig. 3) .
DISCUSSION
Our study clearly shows that when administered by intra-articular injection, MTX-MLV has superior anti-inflammatory properties to either free MTX or MTX-SUV. The improved therapeutic efficacy of MTX-MLV over the other treatments was demonstrated by a rapid reduction (27%) in knee swelling within 24 h, the progressive reduction in joint swelling over the next 20 days and by histological examination of the joint. Only one of the rats dosed with MTX-MLV showed cartilage loss and bone erosion, whereas four rats from the saline-treated group had these changes. These effects correlate with the greater retention of MTX-MLV in the inflamed joint when compared with either free MTX or MTX-SUV. Similar findings have been reported previously with a liposomally conjugated steroid, triamcinolone acetonide-21-palmitate, administered intra-articularly to rabbits with carrageenan-induced arthritis [11] . The liposomal preparation was more efficient than free triamcinolone acetonide in suppressing the arthritis, although the anti-inflammatory effect observed with the liposomal steroid was only twice as great as that observed with the free drug (50% reduction in joint diameter at 21 days compared with ~25%). Using radioactive tracers, it was found that triamcinolone acetonide-21-palmitate incorporated into large liposomes was retained in the articular cavity, together with the liposomal lipids, for a much longer period (20% retention in the joint 24 h post-injection) than free triamcinolone acetonide (0% remaining after 1 h) [11] .
In our study, MTX-MLV (equivalent to 0.2 mg MTX) exerted a rapid anti-inflammatory effect with a significant reduction in knee swelling noted 1 day after injection and by 21 days the swelling had almost completely resolved. Although the anti-inflammatory effect of an intra-articular injection of liposomally encapsulated MTX (equivalent to 0.1 mg MTX) has previously been reported [5] , significant reduction in joint swelling was not seen until 14 days after injection. Knee swelling was reduced by 35%, but no further decrease occurred over the following 2 weeks.
Our MTX-MLV preparation was designed with a view to achieving optimal phagocytic uptake by macrophages [12] in the synovial cavity, consequently the liposomes were formulated with egg lecithin (a low phase transition temperature phospholipid) and only 20 mol% cholesterol. Because of the lipophilic nature of MTX-y-DMPE, a therapeutic dose of MTX (200/ig) was delivered to the joint using 10/imol of liposomal lipid, although this was by no means the lowest lipid concentration that could have been used. Foong and Green [5] used 3-fold more liposomal lipid to ensure that an adequate concentration of MTX (0.1 mg) was encapsulated within the liposome and in order to reduce leakage of this hydrophilic drug from the vesicles, they also incorporated 50 mol% cholesterol into their liposomal preparation. This formulation and the quantity of lipid injected may therefore have saturated the limited endocytic capacity of the synovium [4, 5] and contributed to the modest anti-inflammatory effects seen with this preparation of liposomal MTX. We have previously demonstrated, in vitro, that at lipid doses >15/imol/ml, E-LIPO reduced macrophage viability by 80% and caused complete inhibition of pro-inflammatory mediator release from macrophages [7] . Since the effects of empty liposomes were not investigated by Foong and Green, the anti-inflammatory effect of their liposomal MTX formulation [5] could be explained by the toxic effects of lipid on macrophages. Supporting this view was the observation that a 10-fold increase in encapsulated MTX failed to further enhance the anti-inflammatory effects of their preparation.
The association of MTX-y-DMPE with liposomes substantially improved the therapeutic effect of MTX in the rat antigen-induced arthritis. It is known that, in vitro, liposomes of identical composition to MTX-MLV inhibited macrophage TNFa and PGE 2 release [7] and IL-1 release in vitro and in vivo [8, 13, 14] . In identical experimental systems, free MTX had no inhibitory effects on either IL-1, TNFa or PGE 2 release from rat macrophages, and did not affect the progression of antigen arthritis in our study.
IL-1 and TNFa are involved in the pathogenesis of arthritis and their importance has been demonstrated in a number of animal models [15] [16] [17] [18] [19] [20] [21] [22] [23] . At present, we do not know how the MTX-MLV preparation exerts its beneficial effect in antigen-induced arthritis. Studies are currently in progress to investigate the effects of MTX-MLV on the local production of cytokines within the inflamed tissue and, in view of the reduced cellular infiltrate, the expression of adhesion molecules on the vasculature.
In conclusion, a single intra-articular injection of multilamellar liposomes containing MTX-y-DMPE produced a rapid and sustained anti-inflammatory effect on the course of antigen-induced arthritis in the rat.
